02057nas a2200289   4500008004100000022001400041245010400055210006900159260011100228300001200339490000700351520101200358653002101370653002001391653002101411653002201432653001101454653002301465653002301488653001601511653002201527100003301549700001901582700002101601700001501622856013001637       2015                        eng d  a1386-207300aDesign and development of cheminfocloud: an integrated cloud enabled platform for virtual screening0 aDesign and development of cheminfocloud an integrated cloud enab  aEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATESbBENTHAM SCIENCE PUBL LTDcJAN  a604-6190 v183 a<p>The power of cloud computing and distributed computing has been harnessed to handle vast and heterogeneous data required to be processed in any virtual screening protocol. A cloud computing platorm ChemInfoCloud was built and integrated with several chemoinformatics and bioinformatics tools. The robust engine performs the core chemoinformatics tasks of lead generation, lead optimisation and property prediction in a fast and efficient manner. It has also been provided with some of the bioinformatics functionalities including sequence alignment, active site pose prediction and protein ligand docking. Text mining, NMR chemical shift (1H, 13C) prediction and reaction fingerprint generation modules for efficient lead discovery are also implemented in this platform. We have developed an integrated problem solving cloud environment for virtual screening studies that also provides workflow management, better usability and interaction with end users using container based virtualization, OpenVz.</p>10aChemoinformatics10acloud computing10amachine learning10aMolecular docking10aOpenVz10asequence alignment10aspectra prediction10atext mining10avirtual screening1 aKarthikeyan, Muthukumarasamy1 aPandit, Deepak1 aBhavasar, Arvind1 aVyas, Renu  uhttps://library.ncl.res.in/content/design-and-development-cheminfocloud-integrated-cloud-enabled-platform-virtual-screening-002768nas a2200265   4500008004100000022001400041245013800055210006900193260000900262300001400271490000700285520182600292653002702118653002102145653002202166653003002188653004202218653002202260100002002282700002002302700000502322700003302327700001502360856012702375       2023                        eng d  a0739-110200aComprehensive molecular docking and dynamic simulations for drug repurposing of clinical drugs against multiple cancer kinase targets0 aComprehensive molecular docking and dynamic simulations for drug  cNOV   a7735-77430 v413 a<p>
	Drug repurposing is a method to identify novel therapeutic agents from the existing drugs and clinical compounds. In the present comprehensive work, molecular docking, virtual screening and dynamics simulations were carried out for ten cancer types viz breast, colon, central nervous system, leukaemia, melanoma, ovarian, prostate, renal and lung (non-small and small cell) against validated eighteen kinase targets. The study aims to understand the action of chemotherapy drugs mechanism through binding interactions against selected targets via comparative docking simulations with the state-art molecular modelling suits such as MOE, Cresset-Flare, AutoDock Vina, GOLD and GLIDE. Chemotherapeutic drugs (n = 112) were shortlisted from standard drug databases with appropriate chemoinformatic filters. Based on docking studies it was revealed that leucovorin, nilotinib, ellence, thalomid and carfilzomib drugs possessed potential against other cancer targets. A library was built to enumerate novel molecules based on the scaffold and functional groups extracted from known drugs and clinical compounds. Twenty novel molecules were prioritised further based on drug-like attributes. These were cross docked against 1MQ4 Aurora-A Protein Kinase for prostate cancer and 4UYA Mitogen-activated protein kinase for renal cancer. All docking programs yielded similar results but interestingly AutoDock Vina yielded the lowest RMSD with the native ligand. To further validate the final docking results at atomistic level, molecular dynamics simulations were performed to ascertain the stability of the protein-ligand complex. The study enables repurposing of drugs and lead identification by employing a host of structure and ligand based virtual screening tools and techniques. Communicated by Ramaswamy H. Sarma</p>
10achemotherapeutic drugs10aDrug repurposing10aMolecular docking10amolecular simulation (MD)10astructure-based drug designing (SBDD)10avirtual screening1 aShaikh, Nilofer1 aLinthoi, R., K.1 a1 aKarthikeyan, Muthukumarasamy1 aVyas, Renu  uhttps://library.ncl.res.in/content/comprehensive-molecular-docking-and-dynamic-simulations-drug-repurposing-clinical-drugs